|
See related Viread film-coated tab information |
|
|
|
Manufacturer |
Gilead |
|
Distributor |
LF Asia |
|
Contents |
Tenofovir disoproxil fumarate |
|
Indications |
Treatment of HIV-1 infection in combination w/ other antiretrovirals.
Click to view Viread detailed prescribing infomation |
|
Dosage |
1 tab once daily.
Click to view Viread detailed prescribing infomation |
|
Overdosage |
View Viread overdosage for action to be taken in the event of an overdose. |
|
Administration |
May be taken with or without food (Take consistently either always w/ or always w/o food.). |
|
Contraindications |
[Click for Viread detailed prescribing infomation] |
|
Warnings |
For additional cautionary notes to warn of the potential risk of using the medicine... click to view Viread detailed prescribing infomation |
|
Special Precautions |
Risk factors for liver disease; renal impairment, HIV/HBV co-infection, history of pathologic bone fracture or risk of osteopenia. Pregnancy & lactation. Elderly, childn.
Click to view Viread detailed prescribing infomation |
|
Adverse Drug Reactions |
Mild to moderate GI events eg nausea, diarrhea, vomiting & flatulence. Asthenia, pain, headache; abdominal, back & chest pain; fever, pneumonia, depression, insomnia, peripheral neuropathy, dizziness, rash, sweating, myalgia, wt loss.
View ADR Monitoring Form |
|
Side Effects |
View Viread side effects |
|
Drug Interactions |
Didanosine; drugs that reduce renal function or compete for active tubular secretion may increase serum conc of tenofovir &/or other renally eliminated drugs.
View more drug interactions with Viread |
|
Pregnancy Category (US FDA) |
Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are no controlled studies in pregnant women or animal-reproduction studies have shown an adverse effect (other than a decrease in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is no evidence of a risk in later trimesters). |
|
Storage |
View Viread storage conditions for details to ensure optimal shelf-life. |
|
Description |
View Viread description for details of the chemical structure and excipients (inactive components). |
|
Mechanism of Action |
View Viread mechanism of action for pharmacodynamics and pharmacokinetics details. |
|
Presentation/Packing |
|
Form |
Packing |
Photo |
|
Viread film-coated tablet |
|
Viread 300 mg x 30's |
 |
|
|
|
Manufacturer: |
Gilead |
|
Distributor: |
LF Asia
|
|
|
|
